To understand the pathogenesis of vasculitides, we analyzed how cytoki
ne stimulation of HUVEC in vitro activates the cytotoxic capacity of p
olymorphonuclear (PMN) granulocytes. IL-1 beta, IFN-gamma, or TNF-alph
a caused highly significant dose and time-dependent HUVEC injury, TNF-
alpha-treated HUVEC activated the PMN by means of phospholipase C-rela
ted event, since coincubations conferred PMN to react with a rise of c
ytosolic calcium concentrations, [Ca2+](i), Ab blockade of ICAM-1 on H
UVEC inhibited 50 to 70% of the injury induced by these cytokines, whe
reas a mAb to E-selectin reduced 45 to 65% of IL-1 beta- and TNF-alpha
-, but not IFN-gamma-induced cytotoxicity, The role of nitric oxide (N
O) was of significance since injury induced by each cytokine was reduc
ed by 60 to 87% by specific NO-synthase inhibitors, as well as by scav
enging extracellular NO by oxyhemoglobin. In contrast, injury induced
by TNF-alpha was inhibited by neither superoxide dismutase or catalase
, alpha(1)-antitrypsin, alpha(2)-macroglobulin, nor the platelet-activ
ating factor receptor antagonist WEB-2086, Moreover, PMN from a patien
t with chronic granulomatous disease were fully capable of mediating c
ytotoxicity, The possibility that IL-8, produced by HUVEC in response
to TNF-alpha, mediated activation of PMN was not corroborated since ad
dition of an IL-8-blocking mAb did not modify HUVEC injury, Nonetheles
s, the IL-8 mAb (but not WEB-2086) blocked the rise of [Ca2+](i), Thus
, in this in vitro model of vasculitis, the effect of IL-1 beta, IFN-g
amma, and TNF-alpha as promoters of cytekine-mediated neutrophil-depen
dent injury to HUVEC is a process dependent on expression of adhesion
molecules and probably associated with NO produced in the system.